Is genetic testing of healthy pre-symptomatic children with possible Alport syndrome ethical?

被引：14
|
作者：
Copelovitch, L [1 ]
Kaplan, BS [1 ]
机构：
[1] Childrens Hosp Philadelphia, Dept Pediat, Div Nephrol, Philadelphia, PA 19104 USA
来源：
PEDIATRIC NEPHROLOGY | 2006年 / 21卷 / 04期
关键词：
D O I：
10.1007/s00467-005-0003-4
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
引用
收藏
页码：455 / 456
页数：2
相关论文
共 50 条
  • [31] Genetic prion disease: opportunities for early therapeutic intervention with rigorous pre-symptomatic trials
    Hermann, Peter
    Koch, Jan C.
    Zerr, Inga
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2020, 29 (12) : 1313 - 1316
  • [32] Twenty Years of a Pre-Symptomatic Testing Protocol for Late-Onset Neurological Diseases in Portugal
    Paneque, Milena
    Felix, Joana
    Mendes, Alvaro
    Lemos, Carolina
    Ledo, Susana
    Silva, Joao
    Sequeiros, Jorge
    [J]. ACTA MEDICA PORTUGUESA, 2019, 32 (04): : 295 - 304
  • [33] Alport Syndrome: Clinical Utility of Early Genetic Diagnosis in Children
    Christodoulaki, Vasileia
    Kosma, Konstantina
    Marinakis, Nikolaos M.
    Tilemis, Faidon-Nikolaos
    Stergiou, Nikolaos
    Kampouraki, Afroditi
    Kapogiannis, Charalampos
    Karava, Vasiliki
    Mitsioni, Andromachi
    Mila, Maria
    Kanaka-Gantenbein, Christina
    Makrythanasis, Periklis
    Tzetis, Maria
    Traeger-Synodinos, Joanne
    [J]. GENES, 2024, 15 (08)
  • [34] Global longitudinal strain and quantitative sensory testing in pre-symptomatic patients with mutation for transthyretin amyloidosis
    Canciello, G.
    Tozza, S.
    Lombardi, R.
    Nolano, M.
    Todde, G.
    Severi, D.
    Borrelli, F.
    Acampa, W.
    Esposito, G.
    Manganelli, F.
    Losi, M. A.
    [J]. EUROPEAN HEART JOURNAL, 2022, 43 : 1755 - 1755
  • [35] MOLECULAR TESTING FOR HUNTINGTON DISEASE AND THE RISK OF DISCLOSURE OF UNSOLICITED PRE-SYMPTOMATIC STATUS: A RECURRING THEME
    Miglorini, Elaine Cristina
    Donis, Karina Carvalho
    Castilhos, Raphael
    Saraiva-Pereira, Maria Luiza
    Jardim, Laura Bannach
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2021, 92 : A41 - A41
  • [36] Pre-symptomatic testing for neurodegenerative disorders: Middle- to long-term psychopathological impact
    Ledo, Susana
    Leite, Angela
    Souto, Teresa
    Pimenta Dinis, Maria Alzira
    Sequeiros, Jorge
    [J]. PSICOTHEMA, 2017, 29 (04) : 446 - 452
  • [37] The New Zealand Genetic Frontotemporal Dementia Study (FTDGeNZ): a longitudinal study of pre-symptomatic biomarkers
    Ryan, Brigid
    Baker, Ashleigh O'Mara
    Ilse, Christina
    Brickell, Kiri L.
    Kersten, Hannah M.
    Williams, Joanna M.
    Addis, Donna Rose
    Tippett, Lynette J.
    Curtis, Maurice A.
    [J]. JOURNAL OF THE ROYAL SOCIETY OF NEW ZEALAND, 2023, 53 (04) : 511 - 531
  • [38] Mindfulness-Based Stress Reduction in Pre-symptomatic Genetic Frontotemporal Dementia: A Pilot Study
    Poos, Jackie M.
    van den Berg, Esther
    Papma, Janne M.
    van der Tholen, Fleur C.
    Seelaar, Harro
    Kaat, Laura Donker
    Kievit, J. Anneke
    Tibben, Aad
    van Swieten, John C.
    Jiskoot, Lize C.
    [J]. FRONTIERS IN PSYCHIATRY, 2022, 13
  • [39] People at Risk of Genetic ALS/FTD Want Pre-Symptomatic Treatment: Results of an Online Survey
    Haddad, Cassandra
    Swidler, Jean
    Edelstein, Amy
    Granning, Julie
    Uhrlaub, Mindy
    Olson, Tucker
    Wicks, Paul
    [J]. MUSCLE & NERVE, 2023, 68 : S19 - S20
  • [40] The burden of genetic disease and attitudes towards gene testing in Alport syndrome
    Pajari, H
    Koskimies, O
    Muhonen, T
    Kääriäinen, H
    [J]. PEDIATRIC NEPHROLOGY, 1999, 13 (06) : 471 - 476
12345